par Lehtonen, Enni 
;Bonnaud, F;Melas, Catherine;Lubansu, Alphonse ;Malgrange, B;Chtarto, Abdelwahed ;Velu, Thierry ;Brotchi, Jacques ;Levivier, Marc ;Peschanski, Marc;Tenenbaum, Liliane
Référence NeuroReport, 13, 12, page (1503-1507)
Publication Publié, 2002-08
;Bonnaud, F;Melas, Catherine;Lubansu, Alphonse ;Malgrange, B;Chtarto, Abdelwahed ;Velu, Thierry ;Brotchi, Jacques ;Levivier, Marc ;Peschanski, Marc;Tenenbaum, Liliane Référence NeuroReport, 13, 12, page (1503-1507)
Publication Publié, 2002-08
Article révisé par les pairs
| Résumé : | The success of transplantation of human embryonic mesencephalic tissue to treat parkinsonian patients is limited by the poor survival of the transplant. We show that an AAV2 vector mediates efficient expression of the egfp reporter gene in organotypic cultures of freshly explanted solid fragments of rat embryonic ventral mesencephalon (VM). We observed early and sustained transgene expression (4 days to > or = 6 weeks). Furthermore, rAAV-infected rat embryonic VM transplanted in the adult striatum continued to express EGFP for > or = 3 months. More than 95% of the transduced cells were neurons. Dopaminergic neurons were transduced at low frequency at earlier time points. This method of gene delivery could prove useful to achieve local, continuous secretion of neurotrophic factors at physiologically relevant doses to treat Parkinson's disease. |
